M&A Deal Summary

Eurofins Scientific Acquires Analytical Technology Serviços Analíticos e Ambientais

On July 2, 2014, Eurofins Scientific acquired life science company Analytical Technology Serviços Analíticos e Ambientais

Acquisition Highlights
  • This is Eurofins Scientific’s 25th transaction in the Life Science sector.
  • This is Eurofins Scientific’s 1st transaction in Brazil.

M&A Deal Summary

Date 2014-07-02
Target Analytical Technology Serviços Analíticos e Ambientais
Sector Life Science
Buyer(s) Eurofins Scientific
Deal Type Add-on Acquisition

Target

Analytical Technology Serviços Analíticos e Ambientais

São Paulo, Brazil
Analytical Technology is a company specialized in providing chemical analysis services providing a range of products and solutions developed with differentiated analytical standard. It is also one of the major laboratories for water, air and soil testing, as well as for oil geochemistry analysis.

Search 214,600 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Eurofins Scientific

Luxembourg, Luxembourg

Category Company
Founded 1987
Sector Life Science
Employees65,000
Revenue 7.0B EUR (2024)
DESCRIPTION

Eurofins Scientific is an international group of laboratories providing a unique range of analytical testing services to the pharmaceutical, food, environmental and consumer products industries and to governments. Eurofins Scientific was incorporated in 1987 and is based in Luxembourg City.


DEAL STATS #
Overall 27 of 98
Sector: Life Science M&A 25 of 74
Type: Add-on Acquisition M&A Deals 12 of 73
Country: Brazil M&A 1 of 2
Year: 2014 M&A 10 of 10
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2014-07-01 Viracor-IBT Laboratories

Lee's Summit, Missouri, United States

Viracor-IBT Laboratories, Inc. provides infectious disease testing, immune monitoring, and bioanalytical services to vaccine, pharmaceutical, biotech, and medical device developers.

Buy $255M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2015-02-02 Boston Heart Diagnostics

Framingham,, Massachusetts, United States

Boston Heart utilizes a suite of proprietary diagnostics in combination with additional clinical and genetic tests, extensive cardio-informatics capabilities, and ancillary patient engagement services to provide a advanced diagnostics platform to help identify and reduce the risk of cardiovascular disease, diabetes, and other chronic conditions.

Buy $140M